A eukaryotic typing method, system and storable medium based on core genome multi-site sequences

By processing the typing method of core genome multi-locus sequences in eukaryotes, the genome sequence differences caused by alternative splicing, synonymous mutations and multi-copy genes are solved, and accurate typing results and efficient analysis tools are achieved. , providing support for genetic research of eukaryotes.

CN118366538BActive Publication Date: 2024-11-26ACADEMY OF MILITARY MEDICAL SCIENCES
View PDF 8 Cites 0 Cited by

Patent Information

Application Number
CN202311280846.0
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-09-28
Publication Date
2024-11-26
Estimated Expiration
2043-09-28

AI Technical Summary

Technical Problem

The existing core genome multi-locus sequence typing methods lack consistent typing standards in eukaryotes, and it is difficult to deal with genome sequence differences caused by alternative splicing, synonymous mutations and multi-copy genes, limiting their application.

Method used

By acquiring and assembling sequencing data, gene function annotation and core gene set screening, defining alternative splicing to different genes, synonymous mutations and multi-copy genes because of the same gene, using allelic profiling to calculate correlations between samples , combine background information to perform typing analysis, and build an evolution tree to achieve visualization of kinship.

Benefits of technology

Accurate typing based on multi-locus sequences of core genomes in eukaryotes provides efficient tools for genetic research and population analysis, improves the reliability of typing results, and reduces the occupancy of computing resources and analysis time. .

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118366538B_ABST
    Figure CN118366538B_ABST
Patent Text Reader

Abstract

The present invention provides a eukaryotic typing method, system and storable medium based on core genome multi-site sequences, which relate to the field of bioinformatics analysis. The typing method includes: obtaining sequencing data of samples to be analyzed, assembling genomes based on sequencing data, annotating gene functions, and obtaining gene sets; screening the gene sets to obtain core gene sets, and the screening criteria include: alternative splicing is defined as different genes, synonymous mutations are defined as the same genes, paralogous genes are excluded, and multi-copy genes are defined as the same genes; allele calling is performed by software to obtain an allele spectrum; the correlation between samples to be analyzed is calculated to obtain typing results. The typing method disclosed in the present invention realizes typing of multi-site sequences of the core genome of eukaryotic organisms, and the typing results can be used for geographical traceability and drug resistance judgment, which has important scientific research value.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the field of bioinformatics analysis, and more specifically, relates to a eukaryotic typing method, system, device, computer-readable storage medium and application thereof based on core genome multi-site sequences. Background Art

[0002] Core genome multilocus sequence typing (cgMLST) is a molecular epidemiological method used to study and describe the population structure and evolutionary relationships of prokaryotes. This method is based on multi-site sequence differences in the core genome, and determines the genetic relationship and evolutionary history between different microbial strains by comparing the core genome sequence differences of different microbial strains. The cgMLST method is mainly used in fields such as microbial epidemiology research and clinical infection control. It can be used to track and identify the transmission paths of microorganisms, such as traceability analysis of epidemic outbreaks, investigation and control of foodborne diseases, and tracking and control of hospital-acquired infections. In addition, the cgMLST method can also be used to study the population structure and evolutionary relationships of microorganisms and evaluate the spread and evolution of antibiotic resistance.

[0003] In eukaryotes, due to the existence of alternative splicing, synonymous mutations and multi-copy genes, the genome sequences of eukaryotes vary greatly between different samples, making it difficult to establish consistent typing standards using the cgMLST method. The lack of consistent typing standards limits the application of the cgMLST method in eukaryotes. Summary of the invention

[0004] In response to the problem that the cgMLST method lacks consistent typing standards in eukaryotes, the present application provides a eukaryotic typing method, system, device, computer-readable storage medium and application thereof based on core genome multi-site sequences. The core genes are typed by software, and alternative splicing, synonymous mutations and multi-copy genes are processed, so that the cgMLST method can be accurately applied to eukaryotes.

[0005] The present application discloses a eukaryotic typing method based on core genome multi-site sequences, the method comprising:

[0006] S11: Acquire sequencing data of the sample to be analyzed, and assemble the genome based on the sequencing data of the sample to be analyzed to obtain a full-length genome;

[0007] S12: performing gene function annotation on the full-length genome to obtain a gene set;

[0008] S13: screening the gene set to obtain a first core gene set, wherein the criteria for screening the gene set include: genes in the gene set are present in all samples to be analyzed;

[0009] S14: further screening the first core gene set to obtain a second core gene set, wherein the criteria for further screening the first core gene set include: alternative splicing is defined as different genes, synonymous mutations are defined as the same gene, paralogous genes are excluded, and multi-copy genes are defined as the same gene;

[0010] S15: based on the second core gene set, performing allele calling to obtain an allele spectrum;

[0011] S16: Calculate the correlation between the samples to be analyzed based on the allele spectrum to obtain typing results.

[0012] Furthermore, the method further comprises:

[0013] S21: obtaining sequencing data of the sample to be analyzed and sequencing data of the verification set, and performing genome assembly based on the sequencing data of the sample to be analyzed and sequencing data of the verification set to obtain a full-length genome of the sample to be analyzed and a full-length genome of the verification set;

[0014] S22: performing gene function annotation on the full-length genome of the sample to be analyzed and the full-length genome of the validation set to obtain a gene set of the sample to be analyzed and a gene set of the validation set;

[0015] S23: Screening the sample gene set to be analyzed to obtain a third core gene set, wherein the criteria for screening the sample gene set to be analyzed include: genes in the sample gene set to be analyzed exist in all samples to be analyzed, and the presence rate of genes in the sample gene set to be analyzed in the verification set reaches a threshold;

[0016] S24: further screening the third core gene set to obtain a fourth core gene set, wherein the standard for further screening the third core gene set is the same as S14;

[0017] S25: performing allele calling based on the fourth core gene set to obtain an allele spectrum;

[0018] S26: Calculate the correlation between the samples to be analyzed based on the allele spectrum to obtain typing results.

[0019] Furthermore, the method further comprises:

[0020] S31: Acquire sequencing data of the sample to be analyzed, sequencing data of the validation set, and a reference genome, and perform genome assembly based on the sequencing data of the sample to be analyzed, sequencing data of the validation set, and the reference genome to obtain a full-length genome of the sample to be analyzed with a reference and a full-length genome of the validation set with a reference;

[0021] S32: comparing the full-length genome of the reference sample to be analyzed and the full-length genome of the reference verification set with the reference genome, retaining the samples whose comparison rate and / or the number of fragments of the full-length genome of the reference sample to be analyzed and the full-length genome of the reference verification set after sample assembly meet the conditions, and obtaining qualified samples to be analyzed and qualified verification sets;

[0022] S33: Use the full-length genome of the qualified sample to be analyzed to replace the full-length genome in S12, and then execute S12-S16.

[0023] Furthermore, the method further comprises:

[0024] Execute S11;

[0025] S41: constructing a repetitive sequence database based on the full-length genome, deleting repetitive sequences in the repetitive sequence database in the full-length genome, and obtaining the full-length genome without repetitive sequences;

[0026] S42: Use the full-length genome with the repetitive sequences removed to replace the full-length genome in S11, and then execute S12-S16.

[0027] Furthermore, the typing results realize visualization of the kinship between the samples to be analyzed by constructing an evolutionary tree. During the analysis of the kinship, the background information of the samples to be analyzed is incorporated into the correlation assessment to obtain the relationship between the background information and the allele spectrum; the background information includes any one or more of the following: basic information of the samples, geographical origin of the samples, and drug resistance of the samples.

[0028] Further, the step of analyzing the alternative splicing comprises:

[0029] S61: Read the fasta file that stores sequence information through the Python program to obtain the sequence information;

[0030] S62: If a sequence is different in length from the reference gene, the sequence is written into a new fasta file and then BLAST alignment is performed on the sequence;

[0031] S63: When the coverage and BLAST score of the alignment results reach a threshold, a merge operation is performed, otherwise, a new gene is output.

[0032] Further, the analysis step of the synonymous mutation includes:

[0033] S71: Obtain query column and / or subject column information in the BLAST comparison result file;

[0034] S72: If the gene in the query column and / or subject column is not in the core gene set, then skip this row; otherwise, create a new empty dictionary, and write the name of the gene in the query column and / or subject column as the key;

[0035] S73: write value;

[0036] S731: If the value is empty, save the information of the query and subject columns into a set, {query, subject};

[0037] S732: Otherwise, call the compare function to determine whether the query and subject belong to the same sequence type;

[0038] S7321: If it does not belong to a known sequence type, add {query, subject} as a new sequence type;

[0039] S74: Save the new sequence type to the blank dictionary newd;

[0040] S75: traverse each sequence type in newd, and map each member therein to the same value as the first member of the sequence type;

[0041] S76: Read allele names from the allele spectrum excel file;

[0042] S77: traverse each row of the allele spectrum and split each row to obtain the value of each allele;

[0043] S771: For each cell, if its value is not the default genotype for that gene, replace the value with the value of the first member of the sequence type with the same column name as in the table header;

[0044] S78: Save the value replaced by S771 to a new row.

[0045] A eukaryotic typing system based on core genome multi-site sequences, the system comprising:

[0046] An acquisition unit is used to acquire sequencing data of a sample to be analyzed, and to assemble a genome based on the sequencing data of the sample to be analyzed to obtain a full-length genome;

[0047] Gene structure prediction unit: used to annotate gene functions of the full-length genome to obtain a gene set;

[0048] A first core gene set screening unit is used to screen the gene set to obtain a first core gene set, wherein the criteria for screening the gene set include: genes in the gene set are present in all samples to be analyzed;

[0049] A second core gene set screening unit is used to further screen the first core gene set to obtain a second core gene set, wherein the criteria for further screening the first core gene set include: alternative splicing is defined as different genes, synonymous mutations are defined as the same gene, paralogous genes are excluded, and multi-copy genes are defined as the same gene;

[0050] An allele spectrum construction unit is used to perform allele calling based on the second core gene set to obtain an allele spectrum;

[0051] Typing unit: used to calculate the correlation between the samples to be analyzed based on the allele spectrum to obtain the typing results.

[0052] A eukaryotic typing device based on core genome multi-site sequences, the device comprising: a memory and a processor;

[0053] The memory is used to store program instructions;

[0054] The processor is used to call program instructions, and when the program instructions are executed, it is used to execute the above-mentioned core genome multi-site sequence typing method of eukaryotic organisms.

[0055] A computer-readable storage medium stores a computer program, which, when executed by a processor, implements the above-mentioned eukaryotic typing method based on core genome multi-site sequences.

[0056] Advantages of the present invention:

[0057] 1. The method disclosed in the present application obtains sequencing data of the sample to be analyzed, performs assembly, functional annotation and core gene screening, obtains a core gene set, types the core gene set through software, obtains an allele spectrum, performs correlation calculation based on the allele spectrum, and obtains accurate typing results. This method realizes typing based on core genome multi-site sequences in eukaryotes, and provides an accurate and efficient tool for genetic research and population analysis of eukaryotes.

[0058] 2. When dealing with genetic regulatory mechanisms such as alternative splicing, synonymous mutations and multi-copy genes that do not exist in prokaryotes, the method disclosed in the present application defines alternative splicing as different genes to more accurately distinguish different genotypes; and defines synonymous mutations and multi-copy genes as the same gene to avoid repeated calculations of the same genotype, thereby realizing the application of the cgMLST method in eukaryotes.

[0059] 3. The method disclosed in the present application introduces a validation set, and screens the gene set by determining whether the genes in the gene set of the sample to be analyzed are 100% present in the sample to be analyzed and / or whether the presence rate in the validation set reaches a threshold, thereby obtaining a first core gene set and improving the reliability of the typing results.

[0060] 4. In the process of phylogenetic analysis, the method disclosed in the present application incorporates the background information of the samples to be analyzed into the correlation assessment, including the basic information, geographical origin and drug resistance of the samples, so as to more comprehensively analyze the phylogenetic relationship between the samples and incorporate more background information into the phylogenetic results.

[0061] 5. The method disclosed in the present application constructs a repetitive sequence database based on the full-length genome. First, it tries to avoid erroneous annotations in the genome annotation step; second, it deletes the sequence information in the repetitive sequence database in the full-length genome to obtain the full-length genome without repetitive sequences, thereby reducing the computing resources occupied in the analysis and saving analysis time.

[0062] 6. The method disclosed in the present application realizes automated processing and analysis of alternative splicing and synonymous mutations based on Python scripts. It can traverse all files and subfolders in a folder, automatically identify and process qualified fasta files, and at the same time, by calling external commands to perform BLAST comparison, it can quickly and accurately obtain the comparison results. BRIEF DESCRIPTION OF THE DRAWINGS

[0063] In order to more clearly illustrate the technical solutions in the embodiments of the present invention, the drawings required for use in the description of the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For those skilled in the art, other drawings can be obtained based on these drawings without creative work.

[0064] Figure 1 A schematic diagram of a process flow of a eukaryotic typing method based on core genome multi-site sequences provided by an embodiment of the present invention;

[0065] Figure 2 A schematic diagram of a eukaryotic typing system based on core genome multi-site sequences provided by an embodiment of the present invention;

[0066] Figure 3 This is a schematic diagram of a eukaryotic typing device based on core genome multi-site sequences provided by an embodiment of the present invention;

[0067] Figure 4 A schematic diagram of a Candida auris analysis process of a eukaryotic typing method based on core genome multi-site sequences provided in an embodiment of the present invention;

[0068] Figure 5 The relationship between the Candida auris clades and sequence types analyzed by the eukaryotic typing method based on the core genome multi-locus sequence provided in an embodiment of the present invention;

[0069] Figure 6 The invention provides a method for eukaryotic typing based on core genome multi-site sequences to analyze the relationship between the geographical origin and sequence type of Candida auris;

[0070] Figure 7 The invention discloses a method for eukaryotic typing based on core genome multi-site sequences provided in an embodiment of the invention to analyze the relationship between drug resistance and sequence type of Candida auris. DETAILED DESCRIPTION

[0071] In order to enable those skilled in the art to better understand the solutions of the present invention, the technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the accompanying drawings in the embodiments of the present invention.

[0072] In some of the processes described in the specification and claims of the present invention and the above-mentioned figures, multiple operations that appear in a specific order are included, but it should be clearly understood that these operations may not be executed in the order in which they appear in this article or executed in parallel. The sequence numbers of the operations, such as S101, S102, etc., are only used to distinguish between different operations, and the sequence numbers themselves do not represent any execution order. In addition, these processes may include more or fewer operations, and these operations may be executed in sequence or in parallel. It should be noted that the descriptions of "first", "second", etc. in this article are used to distinguish different messages, devices, modules, etc., do not represent the order of precedence, and do not limit the "first" and "second" to be different types.

[0073] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative work are within the scope of protection of the present invention.

[0074] Figure 1 A method for typing eukaryotic organisms based on core genome multi-site sequences provided by an embodiment of the present invention comprises:

[0075] S11: Acquire sequencing data of the sample to be analyzed, and assemble the genome based on the sequencing data of the sample to be analyzed to obtain a full-length genome;

[0076] In one embodiment, the sample to be analyzed is selected from Candida auris, which is an emerging human fungal pathogen that was first reported to be isolated from the ear canal of a patient in Japan in 2009. Since this initial report, the Centers for Disease Control (CDC) in the United States has reported that Candida auris has evolved into a "serious threat" in healthcare settings and is currently included in the World Health Organization (WHO) Fungal Priority Pathogens List, described as the "most critical" pathogenic fungus.

[0077] Clarifying the molecular typing of Candida auris is an important way to distinguish geographical origins and drug resistance. Whole-genome SNPs were used to distinguish the five branches of Candida auris, and subsequent short tandem repeat sequence typing reduced the technical difficulty and cost of distinguishing branches. However, there has been no association between different strains within the branch and their geographical origins and drug resistance. Core genome multi-sequence typing technology has been widely used in bacteria, including Mycoplasma synoviocytes, Brucella, Yersinia, Listeria monocytogenes, Staphylococcus capitis, Staphylococcus aureus, Streptococcus mutans, and Staphylococcus aureus. cgMLST typing of Staphylococcus capitis successfully distinguished a group of drug-resistant STs.

[0078] In one embodiment, 17 Candida auris strains were newly sequenced using third-generation sequencing technology, and the third-generation sequencing data of 16 strains published in the NCBI database were downloaded. The publicly published flye software was used with default parameters to assemble the third-generation raw sequencing data, and then the publicly published ragtag software was used with default parameters to correct gene boundaries, and finally the full-length genomes of 33 strains were output.

[0079] S12: performing gene function annotation on the full-length genome to obtain a gene set;

[0080] In one embodiment, the PASA genome annotation tool is used to predict the gene model data set. This data set is used to train three publicly published de novo prediction programs, including AUGUSTUS, SNAP and glimmerhmm. The publicly accessible SwissProt protein database is used as protein evidence. EVM is used to combine different prediction schemes to obtain annotation results.

[0081] The PASA genome annotation tool (Program to Assemble Spliced ​​Alignments) is a software tool for genome annotation, mainly used to integrate and analyze splicing alignment data to predict and annotate gene transcripts. PASA can improve the accuracy and completeness of gene structure by integrating splicing alignment data with gene prediction results. It can also perform splicing form verification and new gene discovery by utilizing RNA-Seq data. PASA has flexible configuration options and scalability to adapt to different annotation needs.

[0082] AUGUSTUS is a widely used gene prediction software for identifying and annotating genes from sequences. Based on statistical models and machine learning algorithms, AUGUSTUS can predict coding regions, splicing sites, and splicing forms, etc. It uses known models and training data, combined with information on DNA sequences and splicing sites, to predict genes and generate annotation results. AUGUSTUS has flexible parameter settings and customizable model training functions, which can adapt to the gene prediction needs of different species and data types.

[0083] SNAP (Semi-HMM-based Nucleic Acid Parser): SNAP is a gene prediction tool based on Hidden Markov Model (HMM) for identifying and annotating genes in DNA sequences. SNAP can identify gene features such as coding regions, splicing sites, and splicing forms by constructing and training HMM models. It has efficient and accurate gene prediction capabilities and can adapt to the genome annotation needs of different species and data types.

[0084] GlimmerHMM is a tool for predicting prokaryotic genes based on hidden Markov models and statistical learning algorithms. GlimmerHMM can identify gene features such as coding regions, promoters, terminators, and splicing sites, and generate annotation results for gene structure. It has highly accurate prediction capabilities and is suitable for genome annotation tasks for various bacteria and archaea.

[0085] SwissProt is an internationally recognized protein sequence database that provides high-quality protein annotation information. The SwissProt database provides detailed functional and structural annotations for known protein sequences through manual annotation and literature research. It contains data on a wide range of species and protein families, and provides rich annotation information such as function, structure, modification, subcellular localization, etc. SwissProt is one of the commonly used reference databases in bioinformatics research.

[0086] EVM (Evidence Modeler) is a genome annotation tool used to integrate different sources of evidence. It can integrate different types of annotation information such as alignment-based, RNA-Seq-based, and protein sequence-based. EVM uses weight distribution and decision tree models to generate final gene structure annotations based on different evidence types and qualities. It can improve the accuracy and completeness of gene structure and is suitable for multi-evidence integration tasks in genome annotation.

[0087] The full-length genome sequence output by S11 is input into the above-mentioned genome annotation tool and / or compared with the existing database to output the gene set.

[0088] S13: screening the gene set to obtain a first core gene set, wherein the criteria for screening the gene set include: genes in the gene set are present in all samples to be analyzed;

[0089] In one embodiment, a pan-genome is constructed in the sample to be analyzed using the MCL algorithm, wherein genes present in 100% of the strains are considered to be the core genome.

[0090] The MCL algorithm (Markov Cluster Algorithm) is an algorithm used for cluster analysis, mainly used to analyze modular structures in complex networks. The MCL algorithm is based on random walk processes and matrix operations. By simulating information transmission and aggregation between nodes, it clusters closely connected nodes in the network into the same module. The MCL algorithm is efficient, scalable, and adaptive, and is suitable for cluster analysis of various complex networks, such as protein interaction networks, gene co-expression networks, etc.

[0091] Pan-genome refers to the sum of the core genome shared by all individuals in a species or a population of species and the genome parts that vary and differ between individuals. Pan-genome consists of two parts: the core genome and the accessory genome. The core genome refers to genes that exist in all individuals and have conserved functions and structures; the accessory genome refers to genes that differ between individuals and may be related to specific functions such as adaptation to the environment and resistance.

[0092] The relationship between the MCL algorithm and the pan-genome is that the MCL algorithm can be applied to the discovery of modular structures in pan-genome analysis. By performing network modeling on the similarities or associations between genes in the pan-genome, the MCL algorithm can be used to discover functional modules or gene families in the pan-genome. This can better understand the composition, function, and evolution of the pan-genome, thereby revealing the basis of genetic diversity and adaptability among species or populations. Therefore, the MCL algorithm has important application value in pan-genome research.

[0093] S14: further screening the first core gene set to obtain a second core gene set, wherein the criteria for further screening the first core gene set include: alternative splicing is defined as different genes, synonymous mutations are defined as the same gene, paralogous genes are excluded, and multi-copy genes are defined as the same gene;

[0094] Alternative splicing refers to the process of gene transcription in which different splicing modes can be selected during the splicing of mRNA, thereby producing multiple different mRNA transcripts. Alternative splicing is a common mechanism for regulating gene expression. By changing the composition of transcripts, different protein variants can be produced, thereby increasing the functional diversity of genes. The mechanisms of alternative splicing include changes in splicing site selection, exon skipping, intron retention, and mutually exclusive exons.

[0095] Synonymous mutations are mutations that occur in the DNA sequence, but due to the characteristics of the genetic code, the mutation does not cause a change in the amino acid sequence of the protein. Synonymous mutations occur in the coding region of a gene, where the change of one or more nucleotides does not cause a change in the function of the protein. Synonymous mutations can occur due to the redundancy of the genetic code, that is, multiple codons can encode the same amino acid, or because the mutation of the DNA sequence has no significant effect on the function of the protein.

[0096] Paralogous genes are genes formed by gene duplication or gene family expansion. Paralogous genes appear in the process of evolution due to gene duplication or gene recombination. They are not the same gene at the locus, but have similarities in gene sequence. Paralogous genes may have similar functions, but they may also have different functions. The existence of paralogous genes allows genes to have greater flexibility and diversity in the process of evolution.

[0097] Multicopy genes refer to genes with multiple copies in the genome. The existence of multicopy genes is an important feature of the genome. They may have similar sequences and functions, or they may differentiate and functionally diverge during evolution. The formation of multicopy genes can be due to mechanisms such as gene duplication, gene family expansion or gene transposition. The existence of multicopy genes in the genome can increase the expression and diversity of genes, and play an important role in the adaptability and evolution of species.

[0098] In one embodiment, the step of analyzing alternative splicing comprises:

[0099] S71: read the fasta file storing the sequence information through the Python program to obtain the sequence information;

[0100] S72: If a sequence is different in length from the reference gene, the sequence is written into a new fasta file and then BLAST alignment is performed on the sequence;

[0101] S73: When the coverage and BLAST score of the alignment result meet the threshold, a merge operation is performed; otherwise, a new gene is output.

[0102] In a specific embodiment, the steps of analyzing alternative splicing using a Python script include:

[0103] Input: folder where alleles are stored;

[0104] Output: Allele folders that treat alternative splicing as different genes;

[0105] import os: Import Python's operating system module for handling files and directories.

[0106] import subprocess: Import Python's subprocess module to execute external commands.

[0107] from Bio import SeqIO: Import the SeqIO module from the Biopython library for reading and writing fasta files.

[0108] Traverse all files and subfolders in a folder:

[0109] For each file, check if the file extension is ".fasta" or ".fa", if so, continue processing; otherwise, skip processing.

[0110] Define a function called process_fasta to process each fasta file:

[0111] Read all sequences in the fasta file.

[0112] Create a new fasta file with the original file name minus the extension plus "_different_length.fasta".

[0113] Record the length of the first sequence as the reference length.

[0114] Open new fasta file for writing.

[0115] Iterate over each sequence in the fasta file, and if the length of a sequence is different from the reference length, write it to a new fasta file.

[0116] Finally, call run_blastn(output_file) to perform BLAST alignment on the newly generated fasta file.

[0117] A BLAST command string was constructed to perform all vsall BLAST alignment on the sequences suffixed with "_different_length.fasta".

[0118] Parse the fields of each row, including query sequence ID, target sequence ID, query coverage, and BLAST score ratio.

[0119] When the query coverage is 100% and the BLAST score ratio is greater than 0.8, a merge operation is performed.

[0120] In one embodiment, the step of analyzing synonymous mutations comprises:

[0121] S81: Obtain query column and / or subject column information in the BLAST comparison result file;

[0122] S82: If the gene in the query column and / or subject column is not in the core gene set, skip the row; otherwise, create an empty dictionary and write the name of the gene in the query column and / or subject column as the key;

[0123] S83: write value;

[0124] S831: If the value is empty, save the information of the query and subject columns into a set, {query, subject};

[0125] S832: Otherwise, call the compare function to determine whether the query and subject belong to the same sequence type;

[0126] S8321: If it does not belong to a known sequence type, add {query, subject} as a new sequence type;

[0127] S84: Save the new sequence type to the blank dictionary newd;

[0128] S85: traverse each sequence type in newd, and map each member therein to the same value as the first member of the sequence type;

[0129] S86: Read allele names from the allele spectrum excel file;

[0130] S87: traverse each row of the allele spectrum and split each row to obtain the value of each allele;

[0131] S871: For each cell, if its value is not the default genotype for that gene, replace the value with the value of the first member of the sequence type with the same column name as in the table header;

[0132] S88: Save the value replaced by S771 to a new row.

[0133] In a specific embodiment, the analysis steps of using Python scripts to process synonymous mutations include:

[0134] Input: BLAST alignment result file of alleles and allele profile file.

[0135] Output: Allele spectrum that treats synonymous mutations as identical genotypes.

[0136] Open the BLAST alignment result file and define the query column as t1 and the subject column as t2.

[0137] Check the BLAST alignment for each row to ensure that the genotypes in columns t1 and t2 are present in the allelic spectrum:

[0138] If t1 or t2 is not in the allele spectrum, skip that row.

[0139] Otherwise, continue with the following steps.

[0140] Create an empty dictionary d to store sequence information.

[0141] Extract the gene name from the query and subject columns.

[0142] Initializes the key-value pairs in dictionary d. If the key with name name does not exist in the dictionary, it is added and initialized to an empty list.

[0143] If the list d[name] is empty, add {t1,t2} as a set.

[0144] Otherwise, the compare function is called to determine whether t1 and t2 are of the same sequence type.

[0145] If they do not belong to any known sequence type, {t1, t2} is added as a new sequence type.

[0146] Create a new dictionary newd to store the remapped data.

[0147] Iterate over each sequence type in d and remap each member to the same value as the first member of the sequence type.

[0148] Open the allele profile file and read the allele names.

[0149] Iterate over each row of the allele spectrum and perform the following operations on each row:

[0150] Split each row to get the value for each allele (genotype 1, genotype 2, ...).

[0151] For each cell, if it is not genotype 1 for that gene and its value is not 0, replace its value with the value of the first member of the sequence type with the same column name as in the table header.

[0152] Construct a new row of data and print it out.

[0153] S15: based on the second core gene set, performing allele calling to obtain an allele spectrum;

[0154] In one embodiment, the second core gene set is input, alleles are called by software, and an allelic profile is output. An allelic profile refers to a pattern or combination of different alleles of a gene or a group of genes. An allelic profile is usually composed of alleles at multiple sites, with different allele types at each site. An allelic profile can represent different alleles with numbers, letters or symbols, and is used to describe the allele type of an individual or a strain at a specific site.

[0155] S16: Calculate the correlation between the samples to be analyzed based on the allele spectrum to obtain typing results.

[0156] In one embodiment, the core genes are typed using the publicly available chewBBACA software. chewBBACA is a bioinformatics tool specifically used to analyze and compare bacterial genome sequences. It is an abbreviation for "Bacterial Barcoding and Comparative Genomics", which means bacterial barcoding and comparative genomics. chewBBACA can be used for bacterial population structure analysis, evolutionary relationship inference, comparative genomics research, etc.

[0157] The main functions of chewBBACA include: 1. Core genome multiple sequence alignment, which can quickly build a relationship tree between genomes by aligning the core genomes of multiple bacterial genome sequences, so as to study the evolutionary relationship of bacteria; 2. MLST (multiple locus sequence type) analysis, which can analyze the multiple locus sequences of bacteria according to the known multiple locus sequence type database to determine the subtype and population structure of bacteria; 3. cgMLST (comparative genome multiple locus sequence type) analysis, which can compare bacterial genomes according to the known comparative genome multiple locus sequence type database to determine the subtype and population structure of bacteria, which is used to study the transmission and epidemiology of bacteria; 4. Barcoding analysis, which can determine the species and subspecies of bacteria by analyzing the Barcode sequence in the bacterial genome; 5. Genome quality assessment, which can perform quality assessment on bacterial genome sequences, including the calculation of indicators such as N50, GC content, and gene annotation.

[0158] In one embodiment, the typing results are visualized by constructing an evolutionary tree to visualize the genetic relationship between the samples to be analyzed. Figure 5 The invention discloses a method for eukaryotic typing based on core genome multi-locus sequences provided in an embodiment of the present invention for analyzing the relationship between Candida auris branches and sequence types.

[0159] In a specific embodiment, during the analysis of the kinship, the background information of the sample to be analyzed is included in the correlation assessment to obtain the relationship between the background information and the allele spectrum; the background information includes any one or more of the following: basic information of the sample, geographical origin of the sample, and drug resistance of the sample. Figure 6 The invention provides a method for eukaryotic typing based on core genome multi-site sequences to analyze the relationship between the geographical origin and sequence type of Candida auris; Figure 7 The invention discloses a method for eukaryotic typing based on core genome multi-site sequences provided in an embodiment of the invention to analyze the relationship between drug resistance and sequence type of Candida auris.

[0160] Sequence type (ST) is an identifier that describes the allele composition of a bacterial strain (usually a subspecies or strain of bacteria) at multiple loci. Sequence type is formed by sequencing and aligning multiple gene fragments, determining the allele types on the gene fragments, and then combining these allele types together. Usually, sequence type is determined by the multiple locus sequence typing (MLST) method or the comparative genome multiple locus sequence typing (cgMLST) method.

[0161] There is a close relationship between allele spectrum and sequence type. Allele spectrum is a pattern that describes the allele composition of an individual or a strain at multiple sites, while sequence type is to identify the pattern of these allele compositions. It can be said that allele spectrum is the basis and component of sequence type. According to different combinations of allele spectrum, different sequence types can be determined. Sequence type can be used to study the population structure, evolutionary relationship, transmission and epidemiology of bacteria. At the same time, by comparing the sequence types of different bacterial strains, the relationship and evolutionary distance between them can be inferred. Therefore, allele spectrum and sequence type have important application value in bacterial classification and molecular epidemiological research. In the above-mentioned eukaryotic typing method based on core genome multi-site sequence disclosed in the present application, the application of allele spectrum and sequence type in eukaryotic classification and molecular epidemiological research of Candida auris is realized.

[0162] In one embodiment, the method further comprises:

[0163] S21: obtaining sequencing data of the sample to be analyzed and sequencing data of the verification set, and performing genome assembly based on the sequencing data of the sample to be analyzed and sequencing data of the verification set to obtain a full-length genome of the sample to be analyzed and a full-length genome of the verification set;

[0164] In one embodiment, the inventor team newly sequenced 17 Candida auris strains, combined with the third-generation sequencing data of 16 strains published in the NCBI database to construct a sequencing data set for the samples to be analyzed; the second-generation data of 1,672 strains published in the NCBI database was used as a validation set.

[0165] In one embodiment, the published spades software is used to preliminarily assemble the validation set data using the "--cov-cutoff" parameter. The published ragtag software is then used with default parameters to correct gene boundaries. The full-length genome of the sample to be analyzed and the full-length genome of the validation set are output.

[0166] S22: performing gene function annotation on the full-length genome of the sample to be analyzed and the full-length genome of the validation set to obtain a gene set of the sample to be analyzed and a gene set of the validation set;

[0167] S23: Screening the sample gene set to be analyzed to obtain a third core gene set, wherein the criteria for screening the sample gene set to be analyzed include: genes in the sample gene set to be analyzed exist in all samples to be analyzed, and the presence rate of genes in the sample gene set to be analyzed in the verification set reaches a threshold;

[0168] In one embodiment, the genes in the sample gene set to be analyzed are tested in the validation set, and if the presence rate of the gene in the validation set is not 100% (adjustable to 95%), the third core gene set is eliminated. The threshold is ≥95%.

[0169] S24: further screening the third core gene set to obtain a fourth core gene set, wherein the criteria for further screening the third core gene set are the same as S14, that is, variable splicing is defined as different genes, synonymous mutations are defined as the same gene, paralogous genes are excluded, and multi-copy genes are defined as the same gene;

[0170] S25: performing allele calling based on the fourth core gene set to obtain an allele spectrum;

[0171] S26: Calculate the correlation between the samples to be analyzed based on the allele spectrum to obtain typing results.

[0172] In one embodiment, the method further comprises:

[0173] S31: Obtain a reference genome; in one embodiment, the reference genome is strain B11220.

[0174] S31: Acquire sequencing data of the sample to be analyzed, sequencing data of the validation set, and a reference genome, and perform genome assembly based on the sequencing data of the sample to be analyzed, sequencing data of the validation set, and the reference genome to obtain a full-length genome of the sample to be analyzed with a reference and a full-length genome of the validation set with a reference;

[0175] S32: comparing the full-length genome of the reference sample to be analyzed and the full-length genome of the reference verification set with the reference genome, retaining the samples whose comparison rate and / or the number of fragments of the full-length genome of the reference sample to be analyzed and the full-length genome of the reference verification set after sample assembly meet the conditions, and obtaining qualified samples to be analyzed and qualified verification sets;

[0176] In one embodiment, the genome alignment rate of the reference sample to be analyzed full-length genome and reference validation set full-length genome with strain B11220 needs to be above 85%; the number of fragments after sample assembly is within 500; the genome size after sample assembly is between 10M-14.5M, and the samples to be analyzed and validation set data exceeding these thresholds are excluded. All 33 strains in the samples to be analyzed are qualified, and the data of 1,555 strains in the validation set are finally considered qualified. Remove the unqualified genome sequences to obtain the qualified full-length genome of the sample to be analyzed.

[0177] In one embodiment, data of 1,555 qualified strains in the validation set are also included in the samples to be analyzed, and subsequent analysis is performed to obtain typing results.

[0178] S33: Use the full-length genome of the qualified sample to be analyzed to replace the full-length genome in S12, and then execute S12-S16 (the following is adjusted to S34-S38, S34 corresponds to S12):

[0179] S34: performing gene function annotation on the full-length genome of the qualified sample to be analyzed to obtain a gene set;

[0180] S35: screening the gene set to obtain a first core gene set, wherein the criteria for screening the gene set include: genes in the gene set are present in all samples to be analyzed;

[0181] S36: further screening the first core gene set to obtain a second core gene set, wherein the criteria for further screening the first core gene set include: alternative splicing is defined as different genes, synonymous mutations are defined as the same gene, paralogous genes are excluded, and multi-copy genes are defined as the same gene;

[0182] S37: Based on the second core gene set, perform allele calling to obtain an allele spectrum;

[0183] S38: Calculate the correlation between the samples to be analyzed based on the allele spectrum to obtain typing results.

[0184] In one embodiment, the method further comprises:

[0185] Execute S11: obtain sequencing data of the sample to be analyzed, and assemble the genome based on the sequencing data of the sample to be analyzed to obtain a full-length genome;

[0186] S41: constructing a repetitive sequence database based on the full-length genome, deleting repetitive sequences in the repetitive sequence database in the full-length genome, and obtaining the full-length genome without repetitive sequences;

[0187] In one embodiment, a repetitive sequence database is constructed using the sample to be analyzed, which has been built into the cgMLST scheme and can be used directly without modification. Based on the repetitive sequence database, the repetitive regions in the genome are removed to obtain a full-length genome without repetitive sequences, which can greatly reduce the size of the genome, reduce computing resources, and save computing time.

[0188] S42: Use the full-length genome after removing the repetitive sequences to replace the full-length genome in S11, and then execute S12-S16 (the following is adjusted to S43-S47, S43 corresponds to S12):

[0189] S43: performing gene function annotation on the full-length genome after removing the repetitive sequences to obtain a gene set;

[0190] S44: screening the gene set to obtain a first core gene set, wherein the criteria for screening the gene set include: genes in the gene set are present in all samples to be analyzed;

[0191] S45: further screening the first core gene set to obtain a second core gene set, wherein the criteria for further screening the first core gene set include: alternative splicing is defined as different genes, synonymous mutations are defined as the same gene, paralogous genes are excluded, and multi-copy genes are defined as the same gene;

[0192] S46: based on the second core gene set, performing allele calling to obtain an allele spectrum;

[0193] S47: Calculate the correlation between the samples to be analyzed based on the allele spectrum to obtain typing results.

[0194] The repeat sequence database includes the following sequence types: centromere, low complexity region, RNA repeat, satellite repeat, simple repeat, tandem repeat, LTR long tandem repeat sequence, transposon, etc.

[0195] Repeat sequences refer to the phenomenon that there are multiple identical or similar DNA sequences in the genome. The presence of different types of repeat sequences in the genome has an important impact on the structure, function and evolution of the genome. Among them, the telomere is a special repeat sequence present at the end of the chromosome, which has the function of protecting the stability of the chromosome end. The centromere sequence is usually composed of TTAGGG repeating units. Low complexity regions refer to regions composed of repeated simple sequences, such as long tandem single nucleotide repeats (such as A, T, C, G) or short repeating units (such as ATATAT, AGAGAG, etc.). These sequences exist in multiple copies in the genome, but usually have no clear role in function. RNA repeats are repeat sequences present in RNA molecules. These repeat sequences may affect the stability, transcription, splicing and translation of RNA. Satellite repeats refer to highly repetitive short sequence units present in the genome, usually with a length of dozens to hundreds of base pairs. Satellite repeat sequences are usually enriched in specific regions of chromosomes, such as the nucleolar component region. Simple repeats refer to segments of short sequence units that are repeated in the genome, such as dinucleotide repeats (such as TG, CA) or trinucleotide repeats (such as CAG, CGG). These repeat sequences usually exist in multiple copies in the genome and may be associated with gene mutations in some genetic diseases. Tandem repeats refer to repetitive sequences arranged in tandem in the genome. They can be repetitions of short sequence units (such as microsatellites, which are composed of 2-6 nucleotide repeat units) or repetitions of longer sequence units. Long Terminal Repeat (LTR) is a type of repetitive sequence present in the genome of eukaryotic organisms, usually formed by retrotransposons. The LTR sequence includes two identical inverted repeat sequences, with reverse transcriptase and regulatory elements in the middle. Transposons are a type of DNA sequence that can move and replicate in the genome. Transposons can be divided into two categories: DNA transposons similar to bacteria and retrotransposons similar to viruses. Transposons are widely present in the genome, and their activities can lead to changes in genome structure and alterations in gene regulation.

[0196] In one embodiment, a schematic diagram of the analysis process of Candida auris for executing the above-mentioned eukaryotic typing method based on core genome multi-site sequences is shown in Figure 4 , the analysis process diagram includes sequence typing, removal of duplicate sequences, genome assembly, validation set filtering, removal of duplicate sequences, gene structure prediction, pan-genome construction and core genome screening.

[0197] Figure 2 A eukaryotic typing system based on core genome multi-site sequences is provided in an embodiment of the present invention, and the system comprises:

[0198] 801 acquisition unit: used to acquire sequencing data of the sample to be analyzed, and perform genome assembly based on the sequencing data of the sample to be analyzed to obtain a full-length genome;

[0199] 802 Gene structure prediction unit: used for annotating gene functions of the full-length genome to obtain a gene set;

[0200] 803 a first core gene set screening unit: used to screen the gene set to obtain a first core gene set, wherein the criteria for screening the gene set include: genes in the gene set are present in all samples to be analyzed;

[0201] 804 a second core gene set screening unit: used for further screening the first core gene set to obtain a second core gene set, wherein the criteria for further screening the first core gene set include: alternative splicing is defined as different genes, synonymous mutations are defined as the same gene, paralogous genes are excluded, and multi-copy genes are defined as the same gene;

[0202] 805 allele spectrum construction unit: used for performing allele calling through software based on the second core gene set to obtain an allele spectrum;

[0203] 806 Typing unit: used to calculate the correlation between the samples to be analyzed based on the allele spectrum to obtain the typing result.

[0204] Figure 3 The invention provides a eukaryotic typing device based on core genome multi-site sequences, which includes a memory and a processor; the device may also include an input device and an output device.

[0205] The memory, processor, input device and output device may be connected via a bus or other means. Figure 3 What is shown is a bus connection method as an example; wherein the memory is used to store program instructions; the processor is used to call the program instructions, and when the program instructions are executed, they are used to implement the above-mentioned eukaryotic typing method based on core genome multi-site sequences.

[0206] In some embodiments, the memory may be understood as any storage device for the program, and the processor may be understood as a device for using the program.

[0207] A computer-readable storage medium stores a computer program, which, when executed by a processor, implements the above-mentioned eukaryotic typing method based on core genome multi-site sequences.

[0208] Those skilled in the art can clearly understand that, for the convenience and brevity of description, the specific working processes of the systems, devices and units described above can refer to the corresponding processes in the aforementioned method embodiments and will not be repeated here.

[0209] In the several embodiments provided in the present application, it should be understood that the disclosed systems, devices and methods can be implemented in other ways. For example, the device embodiments described above are only schematic. For example, the division of the units is only a logical function division. There may be other division methods in actual implementation, such as multiple units or components can be combined or integrated into another system, or some features can be ignored or not executed. Another point is that the mutual coupling or direct coupling or communication connection shown or discussed can be an indirect coupling or communication connection through some interfaces, devices or units, which can be electrical, mechanical or other forms.

[0210] The units described as separate components may or may not be physically separated, and the components shown as units may or may not be physical units, that is, they may be located in one place or distributed on multiple network units. Some or all of the units may be selected according to actual needs to achieve the purpose of the solution of this embodiment.

[0211] In addition, each functional unit in each embodiment of the present invention may be integrated into one processing unit, or each unit may exist physically separately, or two or more units may be integrated into one unit. The above-mentioned integrated unit may be implemented in the form of hardware or in the form of software functional units.

[0212] A person of ordinary skill in the art can understand that all or part of the steps in the various methods of the above embodiments can be completed by instructing related hardware through a program, and the program can be stored in a computer-readable storage medium, and the storage medium may include: a read-only memory (ROM), a random access memory (RAM), a disk or an optical disk, etc.

[0213] The above is a detailed introduction to a computer device provided by the present invention. For a person skilled in the art, according to the concept of the embodiments of the present invention, there may be changes in the specific implementation method and application scope. In summary, the content of this specification should not be understood as limiting the present invention.

Claims

1. A eukaryotic typing method based on core genome multi-site sequences, characterized in that: The method comprises: S11: Acquire sequencing data of the sample to be analyzed, and assemble the genome based on the sequencing data of the sample to be analyzed to obtain a full-length genome; S12: performing gene function annotation on the full-length genome to obtain a gene set; S13: screening the gene set to obtain a first core gene set, wherein the criteria for screening the gene set include: genes in the gene set are present in all samples to be analyzed; S14: further screening the first core gene set to obtain a second core gene set, wherein the criteria for further screening the first core gene set include: alternative splicing is defined as different genes, synonymous mutations are defined as the same gene, paralogous genes are excluded, and multi-copy genes are defined as the same gene; S15: based on the second core gene set, performing allele calling to obtain an allele spectrum; S16: Calculate the correlation between the samples to be analyzed based on the allele spectrum to obtain typing results.

2. The eukaryotic typing method based on core genome multi-site sequences according to claim 1, characterized in that: The method further comprises: S21: obtaining sequencing data of the sample to be analyzed and sequencing data of the verification set, and performing genome assembly based on the sequencing data of the sample to be analyzed and sequencing data of the verification set to obtain a full-length genome of the sample to be analyzed and a full-length genome of the verification set; S22: performing gene function annotation on the full-length genome of the sample to be analyzed and the full-length genome of the validation set to obtain a gene set of the sample to be analyzed and a gene set of the validation set; S23: Screening the sample gene set to be analyzed to obtain a third core gene set, wherein the criteria for screening the sample gene set to be analyzed include: genes in the sample gene set to be analyzed exist in all samples to be analyzed, and the presence rate of genes in the sample gene set to be analyzed in the verification set reaches a threshold; S24: further screening the third core gene set to obtain a fourth core gene set, wherein the standard for further screening the third core gene set is the same as S14; S25: performing allele calling based on the fourth core gene set to obtain an allele spectrum; S26: Calculate the correlation between the samples to be analyzed based on the allele spectrum to obtain typing results.

3. The eukaryotic typing method based on core genome multi-site sequences according to claim 1, characterized in that: The method further comprises: S31: Acquire sequencing data of the sample to be analyzed, sequencing data of the validation set, and a reference genome, and perform genome assembly based on the sequencing data of the sample to be analyzed, sequencing data of the validation set, and the reference genome to obtain a full-length genome of the sample to be analyzed with a reference and a full-length genome of the validation set with a reference; S32: comparing the full-length genome of the reference sample to be analyzed and the full-length genome of the reference verification set with the reference genome, retaining the samples whose comparison rate and / or the number of fragments of the full-length genome of the reference sample to be analyzed and the full-length genome of the reference verification set after sample assembly meet the conditions, and obtaining qualified samples to be analyzed and qualified verification sets; S33: Use the full-length genome of the qualified sample to be analyzed to replace the full-length genome in S12, and then execute S12-S16.

4. The eukaryotic typing method based on core genome multi-site sequences according to claim 1, characterized in that: The method further comprises: Execute S11; S41: constructing a repetitive sequence database based on the full-length genome, deleting repetitive sequences in the repetitive sequence database in the full-length genome, and obtaining the full-length genome without repetitive sequences; S42: Use the full-length genome with the repetitive sequences removed to replace the full-length genome in S11, and then execute S12-S16.

5. The eukaryotic typing method based on core genome multi-site sequences according to claim 1, characterized in that: The typing results are visualized by constructing an evolutionary tree to realize the kinship between the samples to be analyzed. In the process of analyzing the kinship, the background information of the samples to be analyzed is included in the correlation evaluation to obtain the relationship between the background information and the allele spectrum; The background information includes any one or more of the following: basic information of the sample, geographical origin of the sample and drug resistance of the sample.

6. The eukaryotic typing method based on core genome multi-site sequences according to claim 1, characterized in that: The step of analyzing alternative splicing comprises: S61: Read the fasta file that stores sequence information through the Python program to obtain the sequence information; S62: If a sequence is different in length from the reference gene, the sequence is written into a new fasta file and then BLAST alignment is performed on the sequence; S63: When the coverage and BLAST score of the alignment results reach a threshold, a merge operation is performed, otherwise, a new gene is output.

7. The eukaryotic typing method based on core genome multi-site sequences according to claim 1, characterized in that: The analysis step of the synonymous mutation comprises: S71: Obtain query column and / or subject column information in the BLAST comparison result file; S72: If the gene in the query column and / or subject column is not in the core gene set, then skip this row; otherwise, create a new empty dictionary, and write the name of the gene in the query column and / or subject column as the key; S73: write value; S731: If the value is empty, save the information of the query and subject columns into a set, {query, subject}; S732: Otherwise, call the compare function to determine whether query and subject belong to the same sequence type; S7321: If they do not belong to a known sequence type, add {query, subject} as a new sequence type; S74: Save the new sequence type to the blank dictionary newd; S75: traverse each sequence type in newd, and map each member therein to the same value as the first member of the sequence type; S76: Read allele names from the allele spectrum excel file; S77: traverse each row of the allele spectrum and split each row to obtain the value of each allele; S771: For each cell, if its value is not the default genotype for that gene, replace the value with the value of the first member of the sequence type with the same column name as in the table header; S78: Save the value replaced by S771 to a new row.

8. A eukaryotic typing system based on core genome multi-site sequences, characterized in that: The system comprises: An acquisition unit is used to acquire sequencing data of a sample to be analyzed, and to assemble a genome based on the sequencing data of the sample to be analyzed to obtain a full-length genome; Gene structure prediction unit: used to annotate gene functions of the full-length genome to obtain a gene set; A first core gene set screening unit is used to screen the gene set to obtain a first core gene set, wherein the criteria for screening the gene set include: genes in the gene set are present in all samples to be analyzed; A second core gene set screening unit is used to further screen the first core gene set to obtain a second core gene set, wherein the criteria for further screening the first core gene set include: alternative splicing is defined as different genes, synonymous mutations are defined as the same gene, paralogous genes are excluded, and multi-copy genes are defined as the same gene; An allele spectrum construction unit is used to perform allele calling based on the second core gene set to obtain an allele spectrum; Typing unit: used to calculate the correlation between the samples to be analyzed based on the allele spectrum to obtain the typing results.

9. A eukaryotic typing device based on core genome multi-site sequences, characterized in that: The device comprises: a memory and a processor; The memory is used to store program instructions; The processor is used to call program instructions, and when the program instructions are executed, it is used to execute the core genome multi-site sequence typing method of eukaryotic organisms described in any one of claims 1-7.

10. A computer-readable storage medium having a computer program stored thereon, characterized in that: When the computer program is executed by a processor, the eukaryotic typing method based on core genome multi-site sequences according to any one of claims 1 to 7 is implemented.

Citation Information

Patent Citations

  • Rapid analysis method and system for genomes of pathogenic microorganisms

    CN106886689A

  • Bioinformatics method based on protein mass spectrum data annotation eukaryote genome

    CN107103205A

  • Salmonella source tracing typing method based on gMLST (genome multilocus sequence typing) technology and application

    CN110714088A

  • Gene alternative splicing analysis method

    CN111863128A

  • Sample pathogenic bacterium typing method and system

    CN113611358A